| Literature DB >> 31812670 |
Abstract
Karyopherin α2 (KPNA2, also known as importinα-1), a member of the nuclear transporter family, is involved in the nucleocytoplasmic transport pathway of a variety of tumor-associated proteins. Recent studies have found that KPNA2 is overexpressed in various cancers, which is associated with poor prognosis. In addition, it has been shown to promote tumor formation and progression by participating in cell differentiation, proliferation, apoptosis, immune response, and viral infection. It is indicated that KPNA2 also plays an important role in the diagnosis, treatment and prognosis of tumors. Herein, we provide an overview of the function and mechanism of KPNA2 in cancer and the prospects in the diagnosis and treatment of cancer. In the future, KPNA2 provides new ideas for the early diagnosis of malignant tumors, the development of molecularly targeted drugs, and prognosis evaluation.Entities:
Keywords: Diagnostic biomarker; KPNA2; Nucleocytoplasmic transport; Tumor progress
Mesh:
Substances:
Year: 2019 PMID: 31812670 DOI: 10.1016/j.lfs.2019.117140
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037